Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Kaneka Corporation (KKA.F)

Compare
20.60
-0.80
(-3.74%)
At close: April 4 at 3:29:02 PM GMT+2
Loading Chart for KKA.F
  • Previous Close 21.40
  • Open 20.40
  • Bid 20.40 x --
  • Ask 23.00 x --
  • Day's Range 20.40 - 20.60
  • 52 Week Range 19.50 - 26.20
  • Volume 19
  • Avg. Volume 0
  • Market Cap (intraday) 1.312B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 7.72
  • EPS (TTM) 2.67
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 0.86 (4.04%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, as well as engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.

www.kaneka.co.jp

11,544

Full Time Employees

March 31

Fiscal Year Ends

Recent News: KKA.F

View More

Performance Overview: KKA.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

KKA.F
147.72%
Nikkei 225 (^N225)
15.33%

1-Year Return

KKA.F
70.25%
Nikkei 225 (^N225)
15.07%

3-Year Return

KKA.F
89.43%
Nikkei 225 (^N225)
21.79%

5-Year Return

KKA.F
37.43%
Nikkei 225 (^N225)
89.56%

Compare To: KKA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KKA.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.43B

  • Enterprise Value

    2.43B

  • Trailing P/E

    8.02

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.28

  • Price/Book (mrq)

    0.47

  • Enterprise Value/Revenue

    0.49

  • Enterprise Value/EBITDA

    8.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.44%

  • Return on Assets (ttm)

    2.77%

  • Return on Equity (ttm)

    6.19%

  • Revenue (ttm)

    800.62B

  • Net Income Avi to Common (ttm)

    27.52B

  • Diluted EPS (ttm)

    2.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    44.48B

  • Total Debt/Equity (mrq)

    42.30%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KKA.F

View More

Company Insights: KKA.F

Research Reports: KKA.F

View More

People Also Watch